Impact of the U.S. Food and Drug Administration cardiovascular assessment requirements on the development of novel antidiabetes drugs (Q36783681)
Jump to navigation
Jump to search
scientific article published on May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of the U.S. Food and Drug Administration cardiovascular assessment requirements on the development of novel antidiabetes drugs |
scientific article published on May 2011 |
Statements
1 reference
Impact of the U.S. Food and Drug Administration cardiovascular assessment requirements on the development of novel antidiabetes drugs (English)
1 reference
Boaz Hirshberg
1 reference
Itamar Raz
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference